These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 773962

  • 21. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing].
    Rubio Peiró A, Liébana Ureña J, Castillo Pérez A, Fernández Crehuet M, Cueto Espinar A, Piédrola Angulo G.
    Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Bacteriophage typing of Shigella sonnei.
    Pruneda RC, Farmer JJ.
    J Clin Microbiol; 1977 Jan; 5(1):66-74. PubMed ID: 319112
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Typing of Proteus mirabilis from clinical sources by computerized analysis of electrophoretic protein patterns.
    Holmes B, Costas M, Wood AC.
    J Appl Bacteriol; 1991 Nov; 71(5):467-76. PubMed ID: 1761440
    [Abstract] [Full Text] [Related]

  • 29. Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris.
    Kappos T, John MA, Hussain Z, Valvano MA.
    J Clin Microbiol; 1992 Oct; 30(10):2632-7. PubMed ID: 1400963
    [Abstract] [Full Text] [Related]

  • 30. Proteus infections in a general hospital. I. Biochemical characteristics and antibiotic susceptibility of the organisms. With special reference to proticine typing and the Dienes phenomenon.
    Adler JL, Burke JP, Martin DF, Finland M.
    Ann Intern Med; 1971 Oct; 75(4):517-30. PubMed ID: 5209286
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Molecular drivers of emerging multidrug resistance in Proteus mirabilis clinical isolates from Algeria.
    Boudjemaa H, Allem R, Fonkou MDM, Zouagui S, Khennouchi NCEH, Kerkoud M.
    J Glob Antimicrob Resist; 2019 Sep; 18():249-256. PubMed ID: 30797091
    [Abstract] [Full Text] [Related]

  • 33. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L, Aleksandrowicz I, Giedrys-Kalemba S.
    Med Dosw Mikrobiol; 1999 Sep; 51(3-4):323-30. PubMed ID: 10803261
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Dienes phenomenon: competition and territoriality in Swarming Proteus mirabilis.
    Budding AE, Ingham CJ, Bitter W, Vandenbroucke-Grauls CM, Schneeberger PM.
    J Bacteriol; 2009 Jun; 191(12):3892-900. PubMed ID: 19251852
    [Abstract] [Full Text] [Related]

  • 37. Survey of multidrug resistance integrative mobilizable elements SGI1 and PGI1 in Proteus mirabilis in humans and dogs in France, 2010-13.
    Schultz E, Haenni M, Mereghetti L, Siebor E, Neuwirth C, Madec JY, Cloeckaert A, Doublet B.
    J Antimicrob Chemother; 2015 Sep; 70(9):2543-6. PubMed ID: 26066582
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Molecular epidemiology of CTX-M-type extended-spectrum β-lactamase-producing Proteus mirabilis isolates in Taiwan.
    Huang CW, Chien JH, Peng RY, Tsai DJ, Li MH, Lee HM, Lin CF, Lee MC, Liao CT.
    Int J Antimicrob Agents; 2015 Jan; 45(1):84-5. PubMed ID: 25446905
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.